| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |